Targeting Enterococcus faecalis HMG-CoA reductase with a non-statin inhibitor. [PDF]
Bose S +9 more
europepmc +1 more source
HMG-CoA reductase inhibitors (statins) versus placebo for people with schizophrenia. [PDF]
Saishoji Y +5 more
europepmc +1 more source
Impaired cortical actin dynamics via lanosterol-dependent HMG-CoA reductase downregulation mediates IFN-α-induced mast cell stabilization. [PDF]
Naskar R +5 more
europepmc +1 more source
Repositioning of HMG-CoA Reductase Inhibitors as Adjuvants in the Modulation of Efflux Pump-Mediated Bacterial and Tumor Resistance. [PDF]
Schelz Z, Muddather HF, Zupkó I.
europepmc +1 more source
Computational identification of epifriedelanol and derived analogs from Mikania cordata as potential HMG-CoA reductase inhibitors. [PDF]
Banu M, Ahmed SS, Begum M, Rahman MO.
europepmc +1 more source
Computational Study of Base-Catalyzed Thiohemiacetal Decomposition in Pseudomonas mevalonii HMG-CoA Reductase. [PDF]
Patel HN +4 more
europepmc +1 more source
Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A (HMG-CoA) Reductase Negative Statin-Induced Necrotizing Myopathy: A Challenging Case. [PDF]
Kaiteris AS, Tripathi R, Ayob G, Ng B.
europepmc +1 more source
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. [PDF]
Tunnicliffe DJ +8 more
europepmc +1 more source
Chronic Anti-HMG-CoA Reductase Positive Necrotizing Myositis With Remote Exposure to Statins. [PDF]
Salar T, Jimenez M, Hameed M, Ocon A.
europepmc +1 more source

